HOXC10 promotes carboplatin resistance of ovarian cancer by regulating ABCC3.
Year: 2022
Type: article
Abstract: . Therefore, the expression of HOXC10/ABCC3 could be a novel biomarker for predicting the carboplatin resistance and the prognosis of OC patients.
Source: PubMed
Authors: Yuanyuan Li, Han Lei, Rihan Hai, Guang Shu, Wenguang Yan, Gang Yin
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4309246365
